Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Journal of Dermatological Science|March 6, 2022
Effectiveness of brodalumab in achieving treatment satisfaction for patients with plaque psoriasis: The ProLOGUE studyShinichi Imafuku, Chika Ohata, Yukari Okubo, et al.
The Journal of Dermatology|May 22, 2024
Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance studyMamitaro Ohtsuki, Yukari Okubo, Hidehisa Saeki, et al.
JAAD International|August 9, 2022
Itch as a critical factor in impaired health-related quality of life in patients with plaque psoriasis achieving clear or almost-clear skin: Analysis of the single-arm, open-label, multicenter, prospective ProLOGUE studyTakuya Miyagi, Yasumasa Kanai, Kenta Murotani, et al.
The Journal of Dermatology|August 19, 2021
Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single centerMiho Mori, Rie Tobita, Chizu Egusa, et al.
The Journal of Dermatology|September 20, 2025
Prospective, Open-Label, Multicenter Study of Apremilast as Maintenance Therapy for Psoriasis Patients in Remission With BiologicsKoji Kamiya, Yukie Yamaguchi, Hidehisa Saeki, et al.
The Journal of Dermatology|September 4, 2024
Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI studyAkimichi Morita, Yukari Okubo, Shinichi Imafuku, et al.
The Journal of Dermatology|August 24, 2023
Real-world retention rates and effectiveness of secukinumab in psoriasis: Results from a multicenter cohort study (RAILWAY)Yayoi Tada, Akimichi Morita, Keiichi Yamanaka, et al.
Modern Rheumatology|February 1, 2024
Modified pustulotic arthro-osteitis diagnostic guidance 2022 - Modified Sonozaki criteria - Secondary publicationShigeyoshi Tsuji, Yukari Okubo, Mitsumasa Kishimoto, et al.
Journal of the American Academy of Dermatology|October 2, 2024
Risk of fungal infection in patients with psoriasis receiving biologics: A retrospective single-center cohort studyYoshihito Minami, Junichiro Hiruma, Kazuharu Harada, et al.
The Journal of Dermatological Treatment|October 21, 2016
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)Kristian Reich, Craig Leonardi, Mark Lebwohl, et al.
Pageof 12